Antiinflammatory and immunoregulatory action of methotrexate in the treatment of rheumatoid arthritis: evidence of increased interleukin-4 and interleukin-10 gene expression demonstrated in vitro by competitive reverse transcriptase-polymerase chain reaction.

No abstract is available for this paper.

• Publication year

  1998

• Venue

  Arthritis & Rheumatism

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1002/1529-0131(199801)41:1<48::AID-ART7>3.0.CO;2-KPMID 9433869
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Low levels of interleukin-4 and high levels of transforming growth factor beta in rheumatoid synovitis.

  2010cited by this paper
• Inhibition of leukotriene B4 synthesis in neutrophils from patients with rheumatoid arthritis by a single oral dose of methotrexate.

  2010cited by this paper
• Role of interleukin-4 and interleukin-10 in murine collagen-induced arthritis. Protective effect of interleukin-4 and interleukin-10 treatment on cartilage destruction.

  1997cited by this paper
• The expanding universe of T-cell subsets: Th1, Th2 and more.

  1996cited by this paper
• Expression of interferon‐gamma (IFN‐δ), IL‐10, IL‐12 and transforming growth factor‐beta (TGF‐β) mRNA in synovial fluid cells from patients in the early and late phases of rheumatoid arthritis (RA)

  1996cited by this paper
• Molecular therapeutics. Methotrexate and its mechanism of action.

  1996cited by this paper
• Interleukin-10 functions as an antiinflammatory cytokine in rheumatoid synovium.

  1996cited by this paper
• Role of cytokines in rheumatoid arthritis.

  1996cited by this paper
• Methotrexate action in rheumatoid arthritis: stimulation of cytokine inhibitor and inhibition of chemokine production by peripheral blood mononuclear cells.

  1995cited by this paper
• Interleukin 6 (IL-6) and soluble IL-2 receptor levels in patients with rheumatoid arthritis treated with low dose oral methotrexate.

  1995cited by this paper
• Effect of methotrexate alone or in combination with sulphasalazine on the production and circulating concentrations of cytokines and their antagonists. Longitudinal evaluation in patients with rheumatoid arthritis.

  1995cited by this paper
• Elevated Th1- or Th0-like cytokine mRNA in peripheral circulation of patients with rheumatoid arthritis. Modulation by treatment with anti-ICAM-1 correlates with clinical benefit.

  1995cited by this paper
• Differential effects of interleukins 10 and 4 on the production of interleukin-6 by blood and synovium monocytes in rheumatoid arthritis.

  1995cited by this paper
• High level of interleukin-10 production by the activated T cell population within the rheumatoid synovial membrane.

  1995cited by this paper
• Elevated interleukin-10 levels in patients with rheumatoid arthritis.

  1995cited by this paper
• Possible mechanisms of action of methotrexate in patients with rheumatoid arthritis.

  1995cited by this paper
• Balance of IL-1 receptor antagonist/IL-1 beta in rheumatoid synovium and its regulation by IL-4 and IL-10.

  1995cited by this paper
• Circulating concentrations and production of cytokines and soluble receptors in rheumatoid arthritis patients: effects of a single dose methotrexate.

  1994cited by this paper
• Divergent T-cell cytokine patterns in inflammatory arthritis.

  1994cited by this paper
• Methotrexate concentrations in synovial membrane and trabecular and cortical bone in rheumatoid arthritis patients.

  1994cited by this paper
• Cytokine combinations increase p75 tumor necrosis factor receptor binding and stimulate receptor shedding in rheumatoid synovial fibroblasts.

  1994cited by this paper
• In vivo production of interleukin-10 by non-T cells in rheumatoid arthritis, Sjögren's syndrome, and systemic lupus erythematosus. A potential mechanism of B lymphocyte hyperactivity and autoimmunity.

  1994cited by this paper
• Immunoregulatory role of interleukin 10 in rheumatoid arthritis

  1994cited by this paper
• Quantitative titration of nucleic acids by enzymatic amplification reactions run to saturation.

  1993cited by this paper
• Circulating soluble tumor necrosis factor receptors, interleukin-2 receptors, tumor necrosis factor alpha, and interleukin-6 levels in rheumatoid arthritis. Longitudinal evaluation during methotrexate and azathioprine therapy.

  1993cited by this paper
• Rheumatoid Inflammatory T‐Cell Clones express mostly Th1 but also Th2 and Mixed (Th0‐Like) Cytokine Patterns

  1993cited by this paper
• Reduction of leukocyte and interleukin-1 beta concentrations in the synovial fluid of rheumatoid arthritis patients treated with methotrexate.

  1993cited by this paper
• The antiinflammatory mechanism of methotrexate. Increased adenosine release at inflamed sites diminishes leukocyte accumulation in an in vivo model of inflammation.

  1993cited by this paper
• Circulating soluble tumor necrosis factor receptors, interleukin‐2 receptors, tumor necrosis factor α, and interleukin‐6 levels in rheumatoid arthritis.

  1993cited by this paper
• Suppression of metalloproteinase biosynthesis in human alveolar macrophages by interleukin-4.

  1992cited by this paper
• The effects of methotrexate on interleukin 1 in patients with rheumatoid arthritis.

  1992cited by this paper
• T Cells Cloned from Human Rheumatoid Synovial Membrane Functionally Represent the Th 1 Subset

  1992cited by this paper
• Long-term prospective study of the use of methotrexate in the treatment of rheumatoid arthritis. Update after a mean of 90 months.

  1992cited by this paper
• Inhibition of the production of proinflammatory cytokines and immunoglobulins by interleukin-4 in an ex vivo model of rheumatoid synovitis.

  1992cited by this paper
• Methotrexate inhibits neutrophil function by stimulating adenosine release from connective tissue cells.

  1991cited by this paper
• Analysis of cytokine mRNA and DNA: detection and quantitation by competitive polymerase chain reaction.

  1990cited by this paper
• How important are T cells in chronic rheumatoid synovitis?

  1990cited by this paper
• Methotrexate: mechanism of action in rheumatoid arthritis.

  1990cited by this paper
• Quantitation of mRNA by the polymerase chain reaction.

  1989cited by this paper
• Increased polyamines may downregulate interleukin 2 production in rheumatoid arthritis.

  1989cited by this paper
• Potential antiinflammatory effects of interleukin 4: suppression of human monocyte tumor necrosis factor alpha, interleukin 1, and prostaglandin E2.

  1989cited by this paper
• Methotrexate pharmacokinetics in patients with rheumatoid arthritis.

  1989cited by this paper
• Inhibition of in vitro vascular endothelial cell proliferation and in vivo neovascularization by low-dose methotrexate.

  1989cited by this paper
• A long-term prospective study of the use of methotrexate in rheumatoid arthritis. Update after a mean of fifty-three months.

  1988cited by this paper
• Impaired Mitogen‐Induced Interferon‐γ Production in Rheumatoid Arthritis and Related Diseases

  1988cited by this paper
• Interferons in rheumatoid arthritis: alterations in production and response related to disease activity.

  1988cited by this paper
• The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis.

  1988cited by this paper
• Impaired mitogen-induced interferon-gamma production in rheumatoid arthritis and related diseases.

  1988cited by this paper
• Comparison of low-dose oral pulse methotrexate and placebo in the treatment of rheumatoid arthritis. A controlled clinical trial.

  1985cited by this paper
• Interleukin-2 in rheumatoid arthritis: production of and response to interleukin-2 in rheumatoid synovial fluid, synovial tissue and peripheral blood.

  1985cited by this paper
• Interferon production of vitro by leucocytes from patients with systemic lupus erythematosus and rheumatoid arthritis.

  1981cited by this paper

• From Cytokines to Biomarkers: Mapping the Immunopathology of Inflammatory Bowel Disease

  2025cites this paper
• Progression of brain injuries associated with methotrexate chemotherapy in childhood acute lymphoblastic leukemia

  2024cites this paper
• Anti-inflammatory Effects of First-line Anti-arthritic Drugs on T-cell Activation

  2022cites this paper
• Semaphorin 3G exacerbates joint inflammation through the accumulation and proliferation of macrophages in the synovium

  2022cites this paper
• Cardiovascular Death Risk in Primary Central Nervous System Lymphoma Patients Treated With Chemotherapy: A Registry-Based Cohort Study

  2021cites this paper
• Significance of Interleukin (IL)-4 and IL-13 in Inflammatory Arthritis

  2021influential citation
• Molecular mechanism of action and pharmacokinetic properties of methotrexate

  2020cites this paper
• Methotrexate—Mechanisms of Drug Action

  2020cites this paper
• Clinical and Radiological Characterization of Patients with Immobilizing and Progressive Stress Fractures in Methotrexate Osteopathy

  2020cites this paper
• Overview of Dual-Acting Drug Methotrexate in Different Neurological Diseases, Autoimmune Pathologies and Cancers

  2020cites this paper
• Perspectives of Methotrexate-Based Radioagents for Application in Nuclear Medicine

  2020cites this paper
• Methotrexate disposition, anti‐folate activity and efficacy in the collagen‐induced arthritis mouse model

  2019cites this paper
• Methotrexate an Old Drug with New Tricks

  2019cites this paper
• Side effects of methotrexate therapy for rheumatoid arthritis: A systematic review.

  2018cites this paper
• Methotrexate preferentially affects Tc1 and Tc17 subset of CD8 T lymphocytes

  2018cites this paper
• Emerging Treatments for Non-infectious Uveitis

  2018cites this paper
• Protective effects of sea cucumber (Holothuria atra) extract on testicular dysfunction induced by immune suppressant drugs in Wistar rats

  2018cites this paper
• Chapter 61 – Traditional DMARDs: Methotrexate, Leflunomide, Sulfasalazine, Hydroxychloroquine, and Combination Therapies

  2017cites this paper
• Pharmacologic Therapy of Ocular Disease

  2017cites this paper
• Giant cell arteritis: beyond temporal artery biopsy and steroids

  2017cites this paper
• Nano-carrier Macrophage Interaction: Role of Secondary Toxicity

  2016cites this paper
• Effects of Methotrexate in a Rabbit Model of In-Stent Neoatherosclerosis: An Optical Coherence Tomography Study

  2016cites this paper
• Inflammation Caused by Nanosized Delivery Systems: Is There a Benefit?

  2016cites this paper
• Immunological evaluation of rheumatoid arthritis patients treated with itolizumab

  2016cites this paper
• Current and emerging treatment options for interstitial lung disease in patients with rheumatic disease

  2016cites this paper
• Methotrexate regulates Th-1 response by suppressing caspase-1 and cytokines in psoriasis patients.

  2016cites this paper
• Pharmacologic Treatment of Noninfectious Uveitis.

  2016cites this paper
• International guidelines of methotrexate use in rheumatic diseases with a focus on rheumatoid arthritis

  2016cites this paper
• Functional analysis of epithelium-specific Ets transcription factor-1 in inflammation

  2016influential citation
• Update on pathogenesis and predictors of response of therapeutic strategies used in inflammatory bowel disease.

  2015cites this paper
• Will Understanding Methotrexate Modes of Action Teach us About Rheumatoid Arthritis

  2015cites this paper
• Lack of association between CXCL9 and CXCL10 gene polymorphisms and the outcome of rheumatoid arthritis treatment with methotrexate.

  2015cites this paper
• Defining Immunological Impact and Therapeutic Benefit of Mild Heating in a Murine Model of Arthritis

  2015cites this paper
• Methotrexate normalized keratinocyte activation cycle by overturning abnormal keratins as well as deregulated inflammatory mediators in psoriatic patients.

  2015cites this paper
• Relief and Resolution of Fibromyalgia Symptoms with Low Dose Methotrexate- The Origin of Pain is Inflammation and the Inflammatory Response

  2014cites this paper
• Methotrexate and a spleen tyrosine kinase inhibitor cooperate to inhibit responses to peripheral blood B cells in rheumatoid arthritis

  2013cites this paper
• Translational medicine from bedside to bench and back again: methotrexate revisited

  2013cites this paper
• 61 – Traditional DMARDs: Methotrexate, Leflunomide, Sulfasalazine, Hydroxychloroquine, and Combination Therapies

  2013cites this paper
• INTRAOCULAR METHOTREXATE CAN INDUCE EXTENDED REMISSION IN SOME PATIENTS IN NONINFECTIOUS UVEITIS

  2013cites this paper
• Enhanced and persistent levels of interleukin (IL)‐17+CD4+ T cells and serum IL‐17 in patients with early inflammatory arthritis

  2013cites this paper
• EFFECT OF INTRAVITREAL METHOTREXATE AND AQUEOUS HUMOR CYTOKINE LEVELS IN REFRACTORY RETINAL VASCULITIS IN BEHCET DISEASE

  2012cites this paper
• Markers of Treatment Response to Methotrexate in Rheumatoid Arthritis: Where Do We Stand?

  2012cites this paper
• A Novel Combination of Methotrexate and Epigallocatechin Attenuates the Overexpression of Pro-inflammatory Cartilage Cytokines and Modulates Antioxidant Status in Adjuvant Arthritic Rats

  2012cites this paper
• The Effect of Methotrexate and Leflunomide on the Cytokine Profile and Nitric Oxide Metabolism in Rheumatoid Arthritis Patients

  2012cites this paper
• The interleukin 1 gene family in systemic juvenile idiopathic arthritis

  2011cites this paper
• The influence of methotrexate on the gene expression of the pro-inflammatory cytokine IL-12A in the therapy of rheumatoid arthritis.

  2011influential citation
• Increased sensitivity to apoptosis induced by methotrexate is mediated by JNK.

  2011cites this paper
• Increased sensitivity to apoptosis induced by methotrexate is mediated by Jun N-terminal kinase

  2011cites this paper
• Persistent Inflammatory Pathways in Rheumatoid Arthritis Despite Anti-rheumatic Treatment

  2010cites this paper
• Fractures of the Proximal Tibia Associated with Longterm Use of Methotrexate: 3 Case Reports and a Review of Literature

  2010cites this paper
• Methotrexate, Leflunomide, Sulfasalazine, Hydroxychloroquine, and Combination Therapies

  2009cites this paper
• Treatment of Connective Tissue Disease-Associated Interstitial Lung Disease

  2009cites this paper
• Methotrexate in Psoriasis : From A to Z

  2009cites this paper
• The role of c-jun N-terminal kinase (JNK) in human T cell function.

  2009cites this paper
• Treatment of experimental adjuvant arthritis with the combination of methotrexate and lyophilizedEnterococcus faecium enriched with organic selenium

  2008cites this paper
• HMGB1 in inflammation - secretion and function

  2008cites this paper
• Systemic Administration of Tolerogenic Dendritic Cells Ameliorates Murine Inflammatory Arthritis

  2008cites this paper
• Distinct in vivo roles of CD80 and CD86 in the effector T‐cell responses inducing antigen‐induced arthritis

  2008cites this paper
• Lactobacillus casei suppresses experimental arthritis by down-regulating T helper 1 effector functions.

  2008cites this paper
• Methotrexate Update: Mechanism of Action in Psoriasis Therapy

  2008cites this paper
• Anti-inflammatory role of methotrexate in adjuvant arthritis: effect on substance p and calcitonin gene-related Peptide in thymus and spleen.

  2007cites this paper
• UvA-DARE ( Digital Academic Repository ) T cell differentiation in autoimmune diseases

  2007cites this paper
• Methotrexate inhibits integrin adhesion molecules in the mouse model of pleurisy induced by carrageenan

  2007cites this paper
• T Cell-Targeted Therapy for Rheumatoid Arthritis

  2007cites this paper
• The Immunology of Rheumatoid Arthritis

  2007cites this paper
• HLA-G 14-bp polymorphism regulates the methotrexate response in rheumatoid arthritis

  2006cites this paper
• Association of cytokine gene polymorphisms and the release of cytokines from peripheral blood mononuclear cells treated with methotrexate and dexamethasone.

  2006cites this paper
• Methotrexate in rheumatoid arthritis.

  2006influential citation
• Antiarthritic and hepatoprotective effect of derinat on adjuvant arthritis in rats

  2006cites this paper
• T cell activation as starter and motor of rheumatic inflammation.

  2006cites this paper
• Revisiting the immunomodulators tacrolimus, methotrexate, and mycophenolate mofetil: Their mechanisms of action and role in the treatment of IBD

  2006cites this paper
• CKBM stimulates MAPKs but inhibits LPS‐induced IFN‐γ in lymphocytes

  2006influential citation
• Atypical cutaneous leishmaniasis in two patients receiving low‐dose methotrexate

  2006cites this paper
• Present and future of combination therapy of autoimmune diseases

  2006cites this paper
• Cytokine profiles in peripheral blood and whole blood cell cultures associated with aggressive periodontitis, juvenile idiopathic arthritis, and rheumatoid arthritis.

  2005cites this paper
• The role of the T cell in autoimmune inflammation

  2005influential citation
• The effect of methotrexate and glucocorticosteroids on apoptosis of phythemaglutinin‐stimulated mononuclear cells from peripheral blood

  2005cites this paper
• Effect of Varying Types of Anti-Arthritic Drugs on TH1 and TH2 Immune Responses in Mice

  2005cites this paper
• IgG subclass distribution of the rheumatoid arthritis‐specific autoantibodies to citrullinated fibrin

  2005cites this paper
• Involvement of P‐glycoprotein in the release of cytokines from peripheral blood mononuclear cells treated with methotrexate and dexamethasone

  2005cites this paper
• IFN‐γ‐producing human T cells directly induce osteoclastogenesis from human monocytes via the expression of RANKL

  2005cites this paper
• Chinese herbs as immunomodulators and potential disease-modifying antirheumatic drugs in autoimmune disorders.

  2004cites this paper
• Predominance of Th 1 cytokine in peripheral blood and pathological tissues of patients with active untreated adult onset Still ’ s disease

  2004cites this paper
• Predominance of Th1 cytokine in peripheral blood and pathological tissues of patients with active untreated adult onset Still’s disease

  2004cites this paper
• Effect of methotrexate on Th1 and Th2 immune responses in mice

  2003cites this paper
• Methotrexate in inflammatory eye disease.

  2003cites this paper
• A molecule solves psoriasis? Systemic therapies for psoriasis inducing interleukin 4 and Th2 responses

  2003cites this paper
• Cyclosporin A and methotrexate are equally effective in reducing T cell numbers in psoriatic skin lesions but have no consistent effect on IFN-γ and IL-4 expression in psoriatic skin in situ

  2003cites this paper
• Molecular action of methotrexate in inflammatory diseases

  2002cites this paper
• Transformation in mycosis fungoides: The role of methotrexate

  2002cites this paper
• In vivo activated T cells in rheumatoid synovitis. Analysis of Th1‐ and Th2‐type cytokine production at clonal level in different stages of disease

  2002cites this paper
• Retroviral Transduction of Antigen-Specific CD4+ T Cells for Local Delivery of Regulatory Molecules

  2002cites this paper
• Folinic acid antagonizes methotrexate-induced differentiation of monocyte progenitors

  2002cites this paper
• Methotrexate in the treatment of rheumatoid arthritis. II. In vivo effects on bone mineral density.

  2002cites this paper
• Methotrexate in the treatment of rheumatoid arthritis. I. In vitro effects on cells of the osteoblast lineage.

  2002cites this paper
• Methotrexate suppresses NF-kappaB activation through inhibition of IkappaBalpha phosphorylation and degradation.

  2001cites this paper
• HLA‐DRB1 gene transcripts in rheumatoid arthritis

  2001cites this paper
• Impaired Th1 cytokine production in spondyloarthropathy is restored by anti-TNFα

  2001cites this paper
• Anti-inflammatory mechanisms of methotrexate in rheumatoid arthritis

  2001cites this paper
• Hereditary predisposition to low interleukin-10 production in children with extended oligoarticular juvenile idiopathic arthritis.

  2001cites this paper